HIT Consultant February 5, 2025
What You Should Know:
– Miist Therapeutics, a pioneering company developing inhaled medicines with a focus on rapid drug delivery raises $7M ina seed funding round led by Refactor Capital with participation from 1517 Fund, Freeflow Ventures, and others,
– The investment will accelerate the development of Miist’s innovative therapies for smoking addiction and migraine.
Fast-Acting Therapies for Smoking Addiction and Migraine
Miist’s therapies address a significant unmet need for faster-acting and more effective treatments for common and debilitating conditions. The company’s initial focus is on smoking addiction and migraine, which affect millions of people worldwide. Miist’s unique approach leverages physics and engineering to deliver drugs directly to the peripheral lung, where they are rapidly absorbed into the...
Today's Sponsors
Today's Sponsor